Medicare Enrolled
Dr. Miguel Valderrabano, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Valderrabano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valderrabano? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valderrabano
Dr. Miguel Valderrabano is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Valderrabano performed 1,063 Medicare services across 878 unique beneficiaries.
Between the years covered by Open Payments, Dr. Valderrabano received a total of $366,384 from 36 pharmaceutical and/or device companies across 1476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valderrabano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ 1,063 Medicare services$ $366,384 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,063
Medicare services
Bottom 31% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
878
Unique beneficiaries
$153
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~56 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 313 | $66 | $212 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 86 | $18 | $102 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 65 | $21 | $112 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 57 | $59 | $624 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 44 | $250 | $1,640 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 43 | $773 | $4,373 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 42 | $250 | $1,638 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 37 | $784 | $4,206 |
| New patient office visit, complex (60-74 min) | 36 | $166 | $600 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 35 | $9 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 32 | $22 | $175 |
| Heart rhythm recording of continous external ekg over 8-15 days | 30 | $10 | $63 |
| Office visit, established patient, complex (40-54 min) | 30 | $132 | $421 |
| Insertion of tube in left heart chamber through heart septum | 29 | $164 | $834 |
| Other cardiovascular service or procedure | 28 | $67 | $657 |
| Office visit, established patient (30-39 min) | 25 | $90 | $314 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 22 | $33 | $268 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 21 | $679 | $3,276 |
| New patient office visit (45-59 min) | 21 | $123 | $483 |
| External shock to heart to regulate heart beat | 20 | $87 | $540 |
| New patient office visit (30-44 min) | 18 | $91 | $317 |
| Repair of left upper heart chamber with implant with review by radiologist | 16 | $588 | $4,197 |
| Insertion of heart rhythm monitor under skin | 13 | $64 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.5% high complexity
5.4% medium
76.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$366,384
Total received (2018-2024)
Avg $52,341/year across 7 years
Top 1% in TX for cardiovascular disease
36
Companies
1,476
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$278,284 (76.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66,123 (18.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,978 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$59,455
2023$149,596
2022$61,933
2021$47,509
2020$14,506
2019$18,506
2018$14,880
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$149,848
Biosense Webster, Inc.
$69,049
Volta Medical Inc
$37,949
Abbott Laboratories
$29,181
Boston Scientific Corporation
$16,615
Medtronic, Inc.
$13,484
Baylis Medical Company Inc
$11,105
BIOTRONIK INC.
$7,492
Novo Nordisk AS
$5,062
ABIOMED
$4,906
BOSTON SCIENTIFIC CORPORATION
$4,886
Impulse Dynamics (USA) Inc.
$4,021
BioSig Technologies, Inc.
$3,000
Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C.
$2,553
Medtronic Vascular, Inc.
$1,679
ATRICURE, INC.
$1,456
Aziyo Biologics, Inc.
$1,085
AltaThera Pharmaceuticals LLC
$1,018
Acutus Medical, Inc.
$449
AtriCure, Inc.
$294
CARDIVA MEDICAL, INC.
$216
Respicardia, Inc.
$166
Janssen Pharmaceuticals, Inc
$160
Medtronic USA, Inc.
$146
PFIZER INC.
$99
SANOFI-AVENTIS U.S. LLC
$98
G Medical Diagnostic Services, Inc.
$82
E.R. Squibb & Sons, L.L.C.
$69
Merck Sharp & Dohme LLC
$46
Siemens Medical Solutions USA, Inc.
$44
Pacira Pharmaceuticals Incorporated
$32
Tactile Systems Technology Inc
$31
Baxter Healthcare
$23
CVRx, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Amgen Inc.
$12
Top 3 companies account for 70.1% of total payments
Associated products mentioned in payments ›
ACCENT · ACUSON SC2000 Diagnostic Ultrasound System · ADAPTA · AFFERA MAPPING SYSTEM · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · ARCTIC FRONT ADVANCE · ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · ATTAIN COMMAND + SUREVALVE · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Acticor 7 VR-T DX · Adapta · Advisa · Advisor Catheter · Agilis NxT EP Introducer · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Arctic Front · Assurity Pacemaker · Azure · BIOMONITOR · Barostim Neo System · CAPSUREFIX NOVUS MRI SURESCAN · CARDIOBLATE · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · Cardiac Mapping System · Cardiac Monitoring Suite · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carto 3 · Carto 3 System · Carto 3 System RMT · Carto Smarttouch · CartoSound · Cartoreplay · Claria MRI · Cobalt · Confirm Rx · CoreValve Evolut · Corlanor · Durata Defibrillation ICD Lead · ECM · ECM Patch · ELIQUIS · EMBLEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENGAGE · ENSITE · ENSITE PRECISION · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EPstar Fixed Electrophysiology Catheter · EVERA MRI XT DR SURESCAN · EXPAREL · Ellipse ICD · EnSite Precision Cardiac Mapping System · EnSite X · Endurant · Ensite Cardiac Mapping System · Evera · FLEXCATH ADVANCE · FORTIFY ASSURA · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL BRADY · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · Gallant CRT-D · HARMONY · Hillrom - Cardiac Ambulatory Monitor · INGEVITY · Impella · JOT DX · KEYTRUDA · LARIAT RS · LARIAT SUTURE DELIVERY DEVICE · LATITUDE · LINQ II · MICRA · MITRACLIP · MRI Ready Leads · MULTAQ · MYCARELINK · Micra · Mitra Clip system · NA · NRG Transseptal Needle · NRG needle · NUVISION ICE CATHETER · Navistar · OCTARAY MAPPING CATHETER · OPTIMIZER · OPTISURE · Occluders · Optimizer · Optimizer Smart System · PERCEPTA QUAD CRT-P MRI SURESCAN · PRADAXA · PULSESELECT · PURE EP SYSTEM · Percepta · Perclose ProGlide suture mediated closure system · Pouch · QDOT MICRO Catheter · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESONATE · RHYTHMIA · Resolute · Reveal LINQ · Rivacor 7 DR-T · SELECTSECURE · SELECTSITE · SENSOR ENABLED · SelectSecure · Solitaire · Sotalol Hydrochloride · Soundstar · SureScan · TACTICATH · TACTICATH ABLATION CATHETER · TENDRIL · THERAPIES · THERMOCOOL SMARTTOUCH · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · Thermocool SF · VIEWMATE · VIGILANT · VX1 · VersaCross Access Solution · ViewFlex Xtra ICE Catheter · Visia AF · Visitag · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for cardiovascular disease in TX.
Equivalent to $34,467 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Valderrabano is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Valderrabano experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Valderrabano performed 313 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valderrabano receive payments from pharmaceutical companies?
Yes. Dr. Valderrabano received a total of $366,384 from 36 companies across 1,476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valderrabano's costs compare to other cardiovascular diseases in Houston?
Dr. Valderrabano's average Medicare payment per service is $153. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valderrabano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
By company
Volta Medical Inc Payments to Doctors
See all physicians who received payments from Volta Medical Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology